A randomised, placebo ‐controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia

BJU International, EarlyView.

Source: BJU International - May 4, 2018 Category: Urology & Nephrology Authors: Kyong Tae Moon , Tag Keun Yoo , Se Yun Kwon , Ji Yong Ha , Seok Soo Byun , Jang Hwan Kim , Jae Il Chung , Tae Hyoung Kim , Hong Sang Moon , Sang Jae Kim , Kyung Seop Lee Source Type: research